Trimethylammonium

Trimethylammonium

SCHEMBL7354979

CC[C@@](CNC(=O)OC(C)(C)C)(NS(=O)(=O)c1c(C)cc(C)cc1C)C(=O)O.CN(C)C

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
PTGER4 P35408 1/20 0.34
MAPT P10636 3/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
EPHX2 P34913 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
ALKBH3 Q96Q83 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7352639 0.85 MAPT (0.36) MAPTEPHX2MEN1KMT2AMAPK1
SCHEMBL7982641 0.82 CA1 (0.40) FABP4CA1CA2MMP1MMP2
Trimethylammonium SCHEMBL7979142 0.78 CA1 (0.40) FABP4CA1CA2MMP1MMP2
SCHEMBL4289710 0.71 CA1 (0.51) FABP4CA1CA2MMP1MMP2
SCHEMBL23846018 0.70 NFKB1 (0.41) FABP4CA1CA2MMP1MMP2
SCHEMBL7448661 0.70 ITGAV (0.59) ALDH1A1ITGAV
SCHEMBL3927817 0.70 NR3C2 (0.51) FABP4CA1CA2MMP1MMP2
SCHEMBL3927823 0.70 NR3C2 (0.51) FABP4CA1CA2MMP1MMP2
SCHEMBL7354160 0.67 ITGAV (0.47) CA1CA2MMP1MMP2MMP9
SCHEMBL7354167 0.67 ITGAV (0.47) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6214834-B1 ANGIOGENESIS INHIBITORS; ANTIINFLAMMATORY AGENTS; ANTICANCER AGENTS DUPONT PHARMACEUTICALS COMPANY 2001-04-10 US disclosed
WO-1998043962-A1 HETEROCYCLIC INTEGRIN INHIBITOR PRODRUGS DU PONT PHARMACEUTICALS COMPANY (US) 1998-10-08 WO disclosed